Vimarsana
Biggest News Aggregation in the World

Page 24 - Quotient Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quotient Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quotient Sciences Today - Breaking & Trending Today

Ensysce Biosciences and Quotient Sciences Announce a Partnership on the Development and Clinical Testing of Ensysce's PF614-MPAR, a Novel Opioid Designed to Prevent Abuse and Overdose - Vimarsana News

Ensysce Biosciences and Quotient Sciences Announce a Partnership on the Development and Clinical Testing of Ensysce's PF614-MPAR, a Novel Opioid Designed to Prevent Abuse and Overdose

/PRNewswire/ -- Ensysce Biosciences, Inc., a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety, and Quotient...

Non-Clinical vs Clinical: Risks & Considerations When Developing Modified Release Dosage Forms, Upcoming Webinar Hosted by Xtalks - Vimarsana News

Non-Clinical vs Clinical: Risks & Considerations When Developing Modified Release Dosage Forms, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) August 29, 2022 -- Oral modified release drug products remain highly prevalent in drug development pipelines. These dosage forms tailor

Source: prweb.com
South Rampart Pharma Announces Late-Breaking Presentation at IASP 2022 World Congress on Pain - Vimarsana News

South Rampart Pharma Announces Late-Breaking Presentation at IASP 2022 World Congress on Pain

NEW ORLEANS, Aug. 25, 2022 /PRNewswire/ -- South Rampart Pharma ('South Rampart' or the 'Company'), a clinical-stage life science company advancin...

South Rampart Pharma Announces Appointment of Josh Blacher as Chief Financial Officer - Vimarsana News

South Rampart Pharma Announces Appointment of Josh Blacher as Chief Financial Officer

NEW ORLEANS, Aug. 16, 2022 /PRNewswire/ -- South Rampart Pharma ('South Rampart' or the 'Company'), a clinical-stage life science company advancin...

Nuformix to continue to optimise value of assets - DirectorsTalk Interviews - Vimarsana News

Nuformix to continue to optimise value of assets - DirectorsTalk Interviews

Nuformix to continue to optimise value of assets